Clinical Trials Directory

Trials / Completed

CompletedNCT00001183

Evaluation of the Causes and Disease Processes of Chronic Lung Disease

Comprehensive Evaluation of the Etiology and Pathogenesis of Chronic Lung Disease (Screening Protocol)

Status
Completed
Phase
Study type
Observational
Enrollment
6,564 (actual)
Sponsor
National Heart, Lung, and Blood Institute (NHLBI) · NIH
Sex
All
Age
7 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Chronic lung diseases are disorders associated with abnormalities in any of the structures involved in the process of breathing and bringing oxygen into the lungs and blood. This includes abnormalities in the airways, lungs, blood vessels in and around the lungs, and the tissue covering the lungs (pleura). The purpose of this research study is to evaluate patients referred to the Cardiovascular and Pulmonary Branch of the National Heart, Lung, and Blood Institute (NHLBI) in order to; 1. Develop a better understanding of the causes and disease processes involved in disorders of the lungs 2. Identify patients eligible to participate in other P-CCMB research studies

Detailed description

The chronic lung diseases are those disorders associated with functional and/or structural derangement to the alveolar structures, airways, pulmonary blood vessels, pleura and/or mediastinum. The purpose of this project is to permit the comprehensive evaluation of patients referred to the Pulmonary Branch of the National Heart, Lung, and Blood Institute (NHLBI) in order to: (1) develop an understanding of the etiology and pathogenesis of these disorders; and (2) identify individuals who will be suitable candidates for other NHLBI protocols. Testing and procedures will only be performed when medically indicated for the purposes of making a diagnosis or obtaining information likely to be useful in the management of the subjects' disease or condition.

Conditions

Timeline

Start date
1984-11-18
Primary completion
2019-12-16
Completion
2019-12-16
First posted
1999-11-04
Last updated
2022-06-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00001183. Inclusion in this directory is not an endorsement.